Liquidia LQDA
NASDAQ LQDA
$68.47 +0.79 (+1.17%)
As of: Sep 9, 2026 · 2:29 PM EDT

Liquidia (LQDA) Change in Receivables (2021 - 2026)

Liquidia (LQDA) posted Change in Receivables of $34.4 million for Q2 2026, up 71.59% on a QoQ basis from $20.1 million in Q1 2026, and up 294.76% year-over-year from $8.7 million in Q2 2025.

Analysis

Liquidia (LQDA) Change in Receivables (2021 - 2026) Analysis & Trends

Liquidia has reported Change in Receivables for 6 years, with the latest figure at $34.4 million in Q2 2026.

  • On a quarterly basis, Change in Receivables rose 294.76% year-over-year to $34.4 million in Q2 2026; TTM through Jun 2026 was $98.6 million, a 1367.72% increase from a year earlier, with the FY2025 full-year figure at $51.4 million, up 3928.17% from the prior year.
  • Change in Receivables was $34.4 million for Q2 2026 at Liquidia, up from $20.1 million in the prior quarter.
  • The five-year high for Change in Receivables was $34.4 million in Q2 2026, with the low at -$1.5 million in Q1 2024.
  • Average Change in Receivables over 5 years is $5.9 million, with a median of $572500.0 recorded in 2022.
  • The largest YoY upside for Change in Receivables was 3235.0% in 2022 against a maximum downside of 1163.79% in 2022.
  • Over 5 years, Change in Receivables stood at $1.9 million in 2022, then sank by 61.56% to $723000.0 in 2023, then slumped by 305.12% to -$1.5 million in 2024, then surged by 1322.79% to $18.1 million in 2025, then jumped by 89.85% to $34.4 million in 2026.
  • The last three Change in Receivables figures came in at $34.4 million (Q2 2026), $20.1 million (Q1 2026), and $18.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn 1.35 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn 1.37 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn -
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn -
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn -
7 Revolution Medicines 44.12 Bn 44.12 Bn - -
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 73.80 Mn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn -1.70 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn 34.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.43 Mn
Mar 31, 2026 20.06 Mn
Dec 31, 2025 18.13 Mn
Sep 30, 2025 25.99 Mn
Jun 30, 2025 8.72 Mn
Mar 31, 2025 -1.47 Mn
Dec 31, 2024 -1.48 Mn
Sep 30, 2024 953,000.00
Jun 30, 2024 679,000.00
Mar 31, 2024 -1.49 Mn
Dec 31, 2023 723,000.00
Sep 30, 2023 -757,000.00
Jun 30, 2023 -36,000.00
Mar 31, 2023 -886,000.00
Dec 31, 2022 1.88 Mn
Sep 30, 2022 -617,000.00
Jun 30, 2022 466,000.00
Mar 31, 2022 297,000.00
Dec 31, 2021 -60,000.00
Sep 30, 2021 58,000.00